Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
,
Founded in 2015
11-50 employees
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2015
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Arvid Wallgrens Backe 20 Västra Götalands Län Göteborg
- City
- Region
- Postal Code
- 413 46
- Country
- Sweden
Web Presence
Websiteobliquet.com
LinkedIn0 followers
